BR Biopharma (NASDAQ:BRBI) Trading 0.4% Higher – Here’s Why

Posted by George Bondi on Jul 4th, 2026

BR Biopharma, Inc. (NASDAQ:BRBI – Get Free Report) traded up 0.4% during trading on Thursday . The company traded as high as $11.29 and last traded at $11.3360. Approximately 266 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 769 shares. The stock had previously closed at $11.29.

Analysts Set New Price Targets

Separately, Weiss Ratings raised BR Biopharma from a “sell (e)” rating to a “sell (d-)” rating in a research note on Thursday, June 4th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

View Our Latest Stock Analysis on BR Biopharma

BR Biopharma Stock Performance

The stock has a fifty day simple moving average of $12.86.

BR Biopharma (NASDAQ:BRBI – Get Free Report) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $0.09 earnings per share for the quarter. The company had revenue of $25.95 million during the quarter.

BR Biopharma Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th were paid a $0.147 dividend. This represents a $0.59 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date of this dividend was Tuesday, May 19th.

Hedge Funds Weigh In On BR Biopharma

An institutional investor recently bought a new position in BR Biopharma stock. Acuitas Investments LLC acquired a new stake in BR Biopharma, Inc. (NASDAQ:BRBI – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma accounts for 3.2% of Acuitas Investments LLC’s investment portfolio, making the stock its 7th biggest holding.

About BR Biopharma

(Get Free Report)

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.